User profiles for R. A. Bonomo
Robert BonomoProfessor, Medicine, Pharmacology, Molecular and Microbiology, and Biochemistry Verified email at va.gov Cited by 65470 |
Extended-spectrum β-lactamases: a clinical update
DL Paterson, RA Bonomo - Clinical microbiology reviews, 2005 - Am Soc Microbiol
Extended-spectrum β-lactamases (ESBLs) are a rapidly evolving group of β-lactamases
which share the ability to hydrolyze third-generation cephalosporins and aztreonam yet are …
which share the ability to hydrolyze third-generation cephalosporins and aztreonam yet are …
Three decades of β-lactamase inhibitors
SM Drawz, RA Bonomo - Clinical microbiology reviews, 2010 - Am Soc Microbiol
Since the introduction of penicillin, β-lactam antibiotics have been the antimicrobial agents
of choice. Unfortunately, the efficacy of these life-saving antibiotics is significantly threatened …
of choice. Unfortunately, the efficacy of these life-saving antibiotics is significantly threatened …
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
Klebsiella pneumoniae carbapenemases (KPCs) were originally identified in the USA in
1996. Since then, these versatile β-lactamases have spread internationally among Gram-…
1996. Since then, these versatile β-lactamases have spread internationally among Gram-…
Global Challenge of Multidrug-Resistant Acinetobacter baumannii
We may soon be facing the end of the “antibiotic era.” The initial and seemingly unstoppable
success of antibiotics, the fruit of human ingenuity, has been countered by an escalation of …
success of antibiotics, the fruit of human ingenuity, has been countered by an escalation of …
Carbapenems: past, present, and future
…, A Endimiani, MA Taracila, RA Bonomo - Antimicrobial agents …, 2011 - Am Soc Microbiol
In this review, we summarize the current “state of the art” of carbapenem antibiotics and
their role in our antimicrobial armamentarium. Among the β-lactams currently available, …
their role in our antimicrobial armamentarium. Among the β-lactams currently available, …
Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosa
RA Bonomo, D Szabo - Clinical infectious diseases, 2006 - academic.oup.com
Acinetobacter species and Pseudomonas aeruginosa are noted for their intrinsic resistance
to antibiotics and for their ability to acquire genes encoding resistance determinants. …
to antibiotics and for their ability to acquire genes encoding resistance determinants. …
Infectious Diseases Society of America guidance on the treatment of AmpC β-lactamase–producing Enterobacterales, carbapenem-resistant Acinetobacter baumannii …
The Infectious Diseases Society of America (IDSA) is committed to providing up-to-date
guidance on the treatment of antimicrobial-resistant infections. A previous guidance document …
guidance on the treatment of antimicrobial-resistant infections. A previous guidance document …
[HTML][HTML] Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients
…, CC Whalen, RA Bonomo… - … England Journal of …, 2000 - Mass Medical Soc
Background Colonization and infection with vancomycin-resistant enterococci have been
associated with exposure to antibiotics that are active against anaerobes. In mice that have …
associated with exposure to antibiotics that are active against anaerobes. In mice that have …
Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges
Acinetobacter is a complex genus, and historically, there has been confusion about the
existence of multiple species. The species commonly cause nosocomial infections, …
existence of multiple species. The species commonly cause nosocomial infections, …
Infectious Diseases Society of America guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant …
Background Antimicrobial-resistant infections are commonly encountered in US hospitals
and result in significant morbidity and mortality. This guidance document provides …
and result in significant morbidity and mortality. This guidance document provides …